| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.098 | 0.0007 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.001 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |